Vol. 25, No. 13 (2013)
Efficient and Facile Synthesis of 1,8-Dioxo-octahydroxanthene Derivatives 7537
TABLE-3
SYNTHESIS OF 1,8-DIOXO-OCTAHYDROXANTHENES* CATALYZED BY Cu(NO ) ·3H O IN ACETONITRILE
3
2
2
m.p. (ºC)
Entry
Aldehyde
C H
τ (h)
Product
Yield (%)
Ref.
(
Found)
(Reported)
b
1
2
3
4
5
6
7
8
9
7.0
9.0
7.0
7.0
7.0
7.0
7.0
8.5
9.5
9.5
7.0
9.0
9.0
9.0
8.0
7.0
7.0
4a
4b
4c
4d
4e
4f
96
89
88
93
81
90
90
94
91
90
90
90
75
80
80
82
86
203-204
228-231
245-247
203-205
224-226
228-229
176
204-205
230-231
246-247
205-206
225-227
226-228
175-177
224-226
171-172
222
11
6
5
b
4-ClC H
6
11
4
b
4-HOC H
6
11
4
2-HOC H
6
18
26
26
4
3-HOC H
6
4
4-HO-3-CH OC H
3
3
6
b
C H CH=CH
6
4g
4h
4i
11
5
b
2-ClC H
6
227
11
4
b
3-NO C H
4
169-170
221-222
218-219
233
11
2
6
b
11
10
11
12
13
14
15
16
17
4-NO C H
4
4j
2
6
b
4-CH C H
4
4k
4l
217-218
234-236
224-226
188-190
183-184
242-245
190-191
11
3
6
4-BrC H
6
18
18
4
4-FC H
6
4m
4n
4o
4p
4q
225
4
b
2-C H N
5
187-189
182-183
244-245
186-188
11
4
b
11
3-ClC H
6
4
4-CH OC H
4
18
18
3
6
2-CH OC H
4
3
6
1
*
All the products are characterized by H NMR, mass and IR spectral analysis.
ready availability, easy handling, cost effectiveness and
remarkably low toxicity with most of the recently reported
catalysts.
Conclusion
A practical and new procedure is developed for the
synthesis of 1,8-dioxo-octahydroxanthene derivatives using
3 2 2
Cu(NO ) ·3H O as catalyst. The present protocol has several
Spectral data for selected compounds
advantages, mild reaction conditions, readily available, inex-
pensive catalyst, easy handling, excellent yields, greater
selectivity, operational and experimental simplicity. Study of
wide range of structurally divergent aldehydes we believe that,
Cu(NO ) ·3H O catalyzed methodology will definitely be a
3
,3,6,6-Tetramethyl-9-benzene-1,8-dioxo-octa-
-1
hydroxanthene (4a): IR (KBr, νmax, cm ): 3154, 1668, 1356,
1
1
274, 1201, 1198, 1138, 867. H NMR (300 MHz, CDCl
ppm): 0.98 (s, 6H, 2CH ), 1.12 (s, 6H, 2CH ) 2.20 (dd, 4H,
CH ), 2.43 (s, 4H, 2CH ), 4.70 (s, 1H, CH), 6.74 (m, 2H,
ArH), 6.95(m,3H, ArH); EI MS (m/z): 350 (M ).
,3,6,6-Tetramethyl-9-(4-chlorophenyl)-1,8-dioxo-
3
δ
3
3
3
2
2
2
2
2
valuable addition to the existing process in the field of synthesis
of 1,8-dioxo-octahydroxanthene derivatives.
+
3
-1
ACKNOWLEDGEMENTS
octahydroxanthene (4b): IR (KBr, νmax, cm ): 3086, 2989,
1
1
2
4
689, 1664, 1640, 1617, 1497, 1366, 1194, 1142, 1121, 1094,
The author thanks Head, Department of Chemistry Dr.
Rita for her cooperation and Jazan University, for giving an
opportunity to continue the research work.
1
021, 846. H NMR (CDCl
CH3), 1.01 (s, 6H, 2CH ), 2.19 (dd, 4H, 2CH
H, 2CH ), 4.72 (s, 1H, CH), 7.52-8.10 (m, 4H, ArH); EI MS
3
, 300 MHz, δ ppm) : 0.88 (s, 6H,
3
2
), 2.51 (dd,
2
(
m/z): 385 (M + 1).
,3,6,6-Tetramethyl-9-(4-nitrophenyl)-1,8-dioxo-
REFERENCES
3
1
.
J. Wichmann, K. Bleicher, E. Vieira, T. Woltering, F Knoflac and V.
Mutel, Farmaco, 57, 989 (2002).
-1
octahydroxanthene (4j): IR (KBr, νmax, cm ): 3081, 2957,
1
7
1
4
666, 1641, 1542, 1492, 1368, 1219, 1170, 1145, 1121, 822,
2. S. Chatterjee, M. Iqbal, J.C. Kauer, J.P. Mallamo, S. Senadhi and S.
Mallya, Bioorg. Med. Chem. Lett., 6, 1619 (1996).
1
48. H NMR (CDCl
3
, 300 MHz, δ ppm) 0.96 (s, 6H, 2CH
), 2.59 (s, 4H, 2CH
3
),
),
3
.
(a)Y. Hamada, F. Matsuura, M. Oku, K. Hatano and T. Shioiri, Tetrahe-
dron Lett., 38 8961 (1997); (b) S. Hillebrand, J. Bruckmann, C. Kruger
and M.W. Haenel, Tetrahedron Lett., 36, 75 (1995); (c) G. Malaise, L.
Barloy and J.A. Osborn, Tetrahedron Lett., 42, 7417 (2001).
(a) S. Hatakeyma N. Ochi, H. Numata and S. Takano, J. Chem. Soc. Chem.
Commun., 1202 (1988) and references cited therein; (b) G.M. Cingolant
and M. Pigini, J. Med. Chem., 12, 531 (1988).
.09 (s, 6H, 2CH ), 2.15 (dd, 4H, 2CH
3
2
2
.48 (s, 1H, CH), 7.16-7.26 (m, 4H, ArH); EI MS (m/z): 396
(
M + 1).
3
4
.
,3,6,6-Tetramethyl-9-(4-bromophenyl)-1,8-dioxo-
-1
octahydroxanthene (4l): IR(KBr, νmax, cm ): 3442, 2932,
1
1
660, 1585, 1362, 1274, 1201, 1138, 1047, 694, 572. H NMR
300 MHz, CDCl , δ ppm), 0.99 (s, 6H, 2CH ); 1.11 (s, 6H,
); 2.10-2.23 (q, 4H, 2CH ); 2.42 (s, 4H, 2CH ); 4.63 (s,
H, CH); 7.12-7.23 (m, 4H, Ar); EI MS (m/z): 429 (M ).
,3,6,6-Tetramethyl-9-(pyridine-2yl)-1,8-dioxo-
5. (a) C.N. O'Callaghan and T.B.H. McMurry, J. Chem. Res. Synop., 214
(1995); J. Chem. Res. Miniprint, 1448 (1995) and references cited therein;
(
3
3
(
b) B. Mirza and S.S. Samiei, Asian J. Chem., 24, 1101 (2012).
(a) J. Robak and R.J. Greglewski, Pol. J. Pharmocol., 48, 55 (1996);
b) H.K. Wang, S.L. M.Natschke and K.H. Lee, Med. Res. Rev., 17, 367
2CH
3
2
2
6
.
+
1
(
3
(1997); (c) A.V. Rukavishnikov, M.P. Smith, G. Birrell, B. Keana and
O.H. Griffith, Tetrahedron Lett., 39, 6637 (1998).
7. E.C. Horning and M.G. Horning, J. Org. Chem., 11, 95 (1946).
-1
octahydroxanthene (4n): IR (KBr, νmax, cm ): 3305, 1685,
1
1
6
4
543, 1011, 874. H NMR (300 MHz, CDCl
3
, δ ppm): 0.96 (s,
), 2.25 (dd, 4H, 2CH ) 2.54 (s,
), 4.71 (s, 1H, CH) 7.35-7.92 (m, 4H, Py); EI MS
8
9
.
.
J.P. Bacci,A.M. Kearney and D.L.Vranken, J. Org. Chem., 70, 9051 (2005).
K. Singh, J. Singh and H. Singh, Tetrahedron, 52, 14273 (1996).
H, 2CH
3
) 1.12 (s, 6H, 2CH
3
2
H, 2CH
2
10. A. Davoodnia, A.Z. Bidaki and H. Behmadi, Chin. J. Catal., 33, 1797
(2012).
(
m/z): 352 (M + 1).